Directly Observed Treatment, Short-course

Directly Observed Treatment, Short-course
Name	Directly Observed Treatment, Short-course
Specialty	Infectious disease, Public health
Invented by	World Health Organization, Centers for Disease Control and Prevention
First used	1990s
Diseases	Tuberculosis, Multidrug-resistant tuberculosis

Contents

Directly Observed Treatment, Short-course is a standardized strategy for ensuring adherence to antimicrobial regimens, developed to combat tuberculosis and improve outcomes for patients with prolonged therapy in diverse settings. The approach was promoted by organizations such as the World Health Organization, the United States Agency for International Development, the Bill & Melinda Gates Foundation and implemented by national programs like the National Tuberculosis Institute and ministries in countries including India, South Africa and China. It has been discussed in forums including the World Health Assembly, the International Union Against Tuberculosis and Lung Disease and publications from the Centers for Disease Control and Prevention, informing policy in regions such as Southeast Asia, Sub-Saharan Africa and Eastern Europe.

Background and Rationale

The strategy originated amid rising concern about tuberculosis treatment failures, driven by reports from institutions like the Royal Society of Medicine, research from the Karolinska Institute and surveillance data from the Global Fund to Fight AIDS, Tuberculosis and Malaria. Early trials and programmatic reviews by the World Health Organization and the European Centre for Disease Prevention and Control highlighted adherence issues seen in settings including Mumbai, Cape Town and St. Petersburg. Influential publications from investigators at the London School of Hygiene & Tropical Medicine, Johns Hopkins University and the Harvard School of Public Health framed directly observed therapy as a response to challenges documented by the Pan American Health Organization and the United Nations.

Implementation typically involves trained observers from institutions such as the Red Cross, Médecins Sans Frontières, local Ministry of Health teams, community health workers linked to programs like Partners In Health and clinic-based staff at facilities like Kenyatta National Hospital. Procedures require daily or intermittent supervised ingestion at locations ranging from clinics run by the NHS to community sites in neighborhoods like Kampala and mobile units modeled after projects in Brazil and Peru. Standard operating procedures were codified in manuals from the World Health Organization, guidelines by the Centers for Disease Control and Prevention and curricula from the Liverpool School of Tropical Medicine, and training often involves partnerships with organizations such as UNICEF and the Rockefeller Foundation.

Program evaluations cited by the World Health Organization, the International Monetary Fund economic reviews, and meta-analyses from teams at the Cochrane Collaboration and Oxford University reported improvements in treatment completion rates in settings including Bangladesh, Philippines and Ethiopia. Outcome studies published by researchers affiliated with McGill University, the University of Cape Town and the University of California, San Francisco documented reductions in relapse rates and transmission in cohorts studied in cities like New York City, Buenos Aires and Jakarta. Large-scale donor-supported initiatives by the Global Fund to Fight AIDS, Tuberculosis and Malaria and programmatic reporting from agencies such as the World Bank linked DOTS implementation to measurable health system gains in provinces of China, districts in Nepal and regions of Mozambique.

Critics from institutions like Amnesty International, scholars at the Open Society Foundations and articles in journals supported by The Lancet and the British Medical Journal raised concerns about coercion, privacy violations, and feasibility in conflict-affected areas such as Syria and Afghanistan. Operational critiques from the Institute of Medicine and analyses by the Brookings Institution emphasized resource intensity and sustainability in low-resource settings including parts of Nigeria and Haiti. Legal and ethical debates occurred in courts and policy forums involving stakeholders like the European Court of Human Rights and national parliaments in Canada and Australia, often juxtaposing individual rights with public health priorities promoted by the World Health Assembly.

Adaptations emerged including community-based models pioneered by Partners In Health in Rwanda and Haiti, family-member observation schemes used in programs supported by the Gates Foundation in India, and digital adherence technologies promoted by collaborations among the World Health Organization, Bill & Melinda Gates Foundation and companies in Silicon Valley. Trials incorporating electronic reminders and video-observed therapy were evaluated by teams at Stanford University, Imperial College London and the Karolinska Institute in pilot sites such as Mumbai, Dar es Salaam and Zambia. Integration with broader initiatives like the Stop TB Partnership and linkages to HIV programs coordinated by UNAIDS and the Global Fund represent programmatic synthesis in settings including Uganda and Malawi.

DOTS and DOT-based policies influenced global strategies promulgated at the World Health Assembly and financed by entities including the Global Fund, USAID and philanthropic institutions like the Clinton Foundation. National tuberculosis programs in countries such as China, India, South Africa, Brazil and Russia adopted DOTS-derived frameworks, contributing to targets in initiatives like the Sustainable Development Goals and the WHO End TB Strategy. Ongoing policy debates involve multilateral agencies including the World Health Organization, regional bodies like the African Union and technical partners such as the Stop TB Partnership, shaping future integration with universal health coverage agendas endorsed by forums like the G20 and the United Nations General Assembly.